SCHEMBL4885696

SCHEMBL4885696

CCOc1cc(Br)cc(Br)c1B(c1c(Br)cc(Br)cc1OCC)c1c(Br)cc(Br)cc1OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.44
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
POLB P06746 1/20 0.34
IGF1R P08069 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
GRM5 P41594 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889777 0.74 NQO1 (0.42) LMNATSHRHSD17B10TDP1NCOA1
SCHEMBL4882818 0.73 LMNA (0.49) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL2870710 0.71 GPR35 (0.43) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL4354925 0.70 THRB (0.55) LMNATSHRHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL1847263 0.69 ALDH1A1 (0.58) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL20764690 0.69 HPGD (0.50) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL10967724 0.69 LMNA (0.57) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL12187513 0.69 LMNA (0.63) LMNATSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL4889763 0.69 THRB (0.42) LMNATSHRHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL4882830 0.69 THRB (0.42) LMNATSHRHSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817318-B1 STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS NIPPON CATALYTIC CHEM IND (JP) 2013-08-28 EP disclosed
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds AR, AHR, BCL6 LMNA 2555/4885TSHR 3726/4885HSD17B10 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.